Etiological Diagnosis of Primary Adrenal Insufficiency Using an Original Flowchart of Immune and Biochemical Markers1
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Approximately 70-80% of cases of primary adrenal insufficiency are classified as idiopathic. An effective protocol for the etiological diagnosis of primary adrenal insufficiency is needed to ensure correct patient management. With the aim of developing an algorithm for the etiological diagnosis of primary adrenal insufficiency, we studied 56 Italian patients with nonsurgical primary adrenal insufficiency and 24 French patients with X-linked adrenoleukodystrophy (ALD) for serum levels of adrenal cortex, steroid-21-hydroxylase (21OHAb), islet cell (ICA), glutamate decarboxylase (GAD65Ab), IA2/ICA512 (ICA512Ab), thyroid peroxidase (TPOAb) autoantibodies, and plasmatic concentrations of very long chain fatty acids (VLCFA). High levels of 21OH and adrenal cortex antibodies were found in 35/42 (83%) and 17/42 (40%) Italian patients with idiopathic adrenal insufficiency, respectively. Levels of adrenal autoantibodies correlated inversely with disease duration (P < 0.0001). Elevated VLCFA were found in 4/42 (10%) idiopathic patients. A total of 34/35 (97%) idiopathic patients with a disease duration of less than 20 yr was positive for either 21OHSAb or elevated levels of VLCFA. None of 14 patients with posttuberculosis adrenal insufficiency had elevated levels of either adrenal antibodies or VLCFA. ICA, GAD65Ab, ICA512Ab, and TPOAb were found in 6/56 (11%), 8/56 (14%), 4/56 (7%), and 23/56 (41%) patients, respectively. None of 24 French ALD patients with adrenal insufficiency was positive for organ-specific autoantibodies. The measuring of 21OH antibodies and plasma VLCFA levels enabled a correct diagnosis of autoimmune (89%) and ALD (8%) in 97% of patients with idiopathic primary adrenal insufficiency of less than 20 yr of duration. The results of our study have important therapeutic and prognostic implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis
Lin, D., Sugawara, T., Strauss, J. F., Clark, B. J., Stocco, D. M., Saenger, P., Rogol, A., & Miller, W. L. (1995) · Science · doi:10.1126/science.7892608 · Cited by 1,030 · cited 2×
“These include congenital lipoid adrenal hyperplasia ( 21 ), adrenal hypoplasia congenita (22), triple A syndrome (23), and adrenoleukodystrophy (ALD) (24 ‐27).”
Background21-hydroxylase, a major autoantigen in idiopathic Addison's disease
Winqvist, O., Karlsson, F. A., & Kämpe, O. (1992) · The Lancet · doi:10.1016/0140-6736(92)91829-w · Cited by 410 · cited 1×
“However, in spite of their high diagnostic sensitivity, 10 ‐30% of idiopathic patients cannot be accounted for by ACA (6, 7). The identification of a major adrenal autoantigen as steroid-21hydroxylase (21OHAb) ( 11 , 12) recently enabled the development of a sensitive radiobinding assay for 21OHAb, which was shown to…”
BackgroundAubourg, P., Blanche, S., Jambaqué, I., Rocchiccioli, F., Kalifa, G., Naud-Saudreau, C., Rolland, M.-O., Debré, M., Chaussain, J.-L., Griscelli, C., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222607 · Cited by 366 · cited 1×
“Half of the cases of ALD involve children for whom there is no cure except when bone marrow transplantation at an early stage can be proposed ( 41 , 42).”
BackgroundSelf-citationA Two-Year Trial of Oleic and Erucic Acids (“Lorenzo's Oil”) as Treatment for Adrenomyeloneuropathy
Aubourg, P., Adamsbaum, C., Lavallard-Rousseau, M.-C., Rocchiccioli, F., Cartier, N., Jambaque, I., Jakobezak, C., Lemaitre, A., Boureau, F., Wolf, C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309093291101 · Cited by 242
Self-citationWinqvist, O., Gustafsson, J., Rorsman, F., Karlsson, F. A., & Kämpe, O. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116843 · Cited by 201 · cited 1×
“It has also been proposed that steroid-17-hydroxylase (17OH) and side-chain cleavage enzyme would be targets of autoantibodies in the autoimmune polyglandular syndrome type I (APS I) (15, 16 ).”
BackgroundAssociated Autoimmunity in Addison's Disease
Zelissen, P. M. J., Bast, E. J. E. G., & Croughs, R. J. M. (1995) · Journal of Autoimmunity · doi:10.1006/jaut.1995.0009 · Cited by 190
The natural history of adrenal function in autoimmune patients with adrenal autoantibodies
Betterle, C., Scalici, C., Presotto, F., Pedini, B., Moro, L., Rigon, F., & Mantero, F. (1988) · Journal of Endocrinology · doi:10.1677/joe.0.1170467 · Cited by 155
Laureti, S., Casucci, G., Santeusanio, F., Angeletti, G., Aubourg, P., & Brunetti, P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636252 · Cited by 101
Self-citationAUBOURG, P., & MANDEL, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18637.x · Cited by 58
Self-citation
Cited by
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
“…the vast majority of adult cases, and screening for specific auto-antibodies against CYP21A2 and for other associated autoimmune diseases is important, keeping in mind that the laboratory tests for the autoantibodies are not standardized and are subject to wide between-method variation (7, 76–79).”
BackgroundBetterle, C., Dal Pra, C., Mantero, F., & Zanchetta, R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0466 · Cited by 758
“roid disease or type 1 diabetes mellitus (174, 175, 254).”
BackgroundCharmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Engelen, M., Kemp, S., de Visser, M., van Geel, B. M., Wanders, R. J., Aubourg, P., & Poll-The, B. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-51 · Cited by 562
Self-citationBendre, M. S., Montague, D. C., Peery, T., Akel, N. S., Gaddy, D., & Suva, L. J. (2003) · Bone · doi:10.1016/s8756-3282(03)00086-3 · Cited by 428
Metadata
- Authors
- Laureti, S., Aubourg, P., Calcinaro, F., Rocchiccioli, F., Casucci, G., Angeletti, G., Brunetti, P., Lernmark, Å., Santeusanio, F., & Falorni, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-09
- Volume
- 83
- Issue
- 9
- Pages
- 3163-3168
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2149763104
- Cited by
- 66
- References
- 9
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Etiological Diagnosis of Primary Adrenal Insufficiency Using an Original Flowchart of Immune and Biochemical Markers1. https://app.cochat.ai/papers/10.1210/jcem.83.9.5103
- The paper
- Laureti, S., Aubourg, P., Calcinaro, F., Rocchiccioli, F., Casucci, G., Angeletti, G., Brunetti, P., Lernmark, Å., Santeusanio, F., & Falorni, A. (1998). Etiological Diagnosis of Primary Adrenal Insufficiency Using an Original Flowchart of Immune and Biochemical Markers1. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.83.9.5103
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.